Dr. Catherine Diaz-Asper presented her research on using artificial intelligence to detect cognitive decline at the 2023 Clinical Trials on Alzheimer’s Disease conference in late October. Her approach analyzes speech by combining advances in artificial intelligence with the convenience of the telephone to develop a screening tool that could reach many more people than current methods.
